Trial Profile
A Randomized, Open-label, Single-Dose, 2-Treatment, 2-Way, 2-Period Crossover Study to Compare the Pharmacokinetic Characteristics Between Rosuvastatin 20mg and Ezetimibe 10mg co-administration and Rosuvastatin/Ezetimibe complex product in Healthy Male Korean Subjects
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 18 Sep 2019
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary) ; Ezetimibe/rosuvastatin (Primary) ; Rosuvastatin (Primary)
- Indications Hypercholesterolaemia
- Focus Pharmacokinetics
- Acronyms ID-ROEZ-101
- Sponsors Ildong Pharmaceutical
- 06 Sep 2016 New trial record